<DOC>
	<DOC>NCT00482430</DOC>
	<brief_summary>The purpose of this study is to determine the safety and effectiveness of an investigational drug for the treatment of cognitive impairment in patients with schizophrenia.</brief_summary>
	<brief_title>MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Schizophrenia, Paranoid</mesh_term>
	<criteria>Patient is clinically stable, on current antipsychotic medication for at least 3 months and current dose for 2 months Patient has a 6th grade reading level or better and has completed at least 6 years of formal education Females are not pregnant, and those who can have children agree to remain abstinent or use acceptable birth control throughout study Patient has had a stable living arrangement for at least 3 months prior to study start Patient is in general good health based on screening assessments Patient has a major disease/disorder that may interfere with cognitive testing (such as mental retardation) and/or pose a risk upon study participation Patient has a history of head trauma with loss of consciousness greater than 15 minutes Patient has had warfarin treatment, MAO inhibitors, clonazepam, clozapine or St. John's wort within 1 month of screening Patient has had ECT treatment within 6 months of screening Patient requires treatment with antihistamines or certain other medications listed in the protocol Patient has a history of liver disease that has been active within the last 2 years, or a history of cancer within past 5 years Patient has a history of alcohol or drug dependence within past year or alcohol or drug abuse within 3 months of screening</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Undifferentiated schizophrenia</keyword>
	<keyword>Residual schizophrenia</keyword>
</DOC>